At a glance · for buyers and watchdogs
C. S. T. PHARMA LIMITED has won £1.1bn across 8 public-sector buyers, with 55 live contracts. No active Companies House risk flags.
Why: top buyer NHS England at 96% · 0 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS Framework Agreement, Branded Medicines for London and South of England
- NHS Framework for the North of England, Branded Medicine
- NHS Framework Agreement for Branded medicines - National
- Framework Agreement for the Provision of Balanced Salt Solution Products
Extracted automatically from cstpharma.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships · 1
Credentials listed on the supplier’s website. Not yet checked against issuer registers.
Extracted automatically from cstpharma.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 55 live · 17 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| NHS England | — | 01 Jun 2026 | £529.1m | 1.9 yrs | pending | |
| NHS England | — | 01 Jun 2026 | £403.7m | 2 yrs | pending | |
| NHS England | 33600000 | 01 Sept 2025 | £9.4m | 2 yrs | Live | |
| NHS England North East and Yorkshire Health and Justice | — | 01 Sept 2025 | £22.1m | 17 mo | pending | |
| NHS England North East and Yorkshire Health and Justice | — | 01 Sept 2025 | £22.1m | 17 mo | pending | |
| NHS England | 33600000 | 01 May 2024 | £11.2m | 4 yrs | Live | |
| NHS England | 33600000 | 01 Jun 2024 | £0.02 | 3 yrs | Live | |
| NHS England | 33600000 | 01 Mar 2024 | £17.6m | 2.5 yrs | Live | |
| University Hospitals of Derby and Burton NHS Foundation Trust | 33600000 | 01 Feb 2024 | £0.17 | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Sept 2023 | £6.4m | 2 yrs | Closed |
Top buyers · 8 buyers · top 3 = 100%
Share of awarded value. Concentration fires above 40% for any single buyer.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). C. S. T. PHARMA LIMITED highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
CS C. S. T. PHARMA LIMITED | Yes | £932.8m | — |
| Yes | £121.0m | 22 | |
| Yes | £117.6m | 18 | |
| Yes | £95.2m | 12 | |
| Yes | £72.5m | 12 | |
| Yes | £71.2m | 21 |
Red flags · 0 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 04212740
- Status
- Active
- Type
- Private limited
- Incorporated
- 09 May 2001
- Reg. office
- Unit 5-7 Tintagel Way, Westgate Park Industrial Estate Aldridge, Walsall, WS9 8ER
- SIC codes
- 46460
- Last accounts
- 30 Apr 2025
- Next accounts due
- 31 Jan 2027
Directors & PSC
- PRITCHARD, Ian — directorAppointed 05 Aug 2019
- FALZON, Carl Robert — directorAppointed 28 Aug 2018
- POYNTER, Caroline — directorAppointed 28 Aug 2018
- YATES, Jason Derick — directorAppointed 28 Aug 2018
- Cst Pharma Group Holdings — person with significant controlownership of shares 75 to 100 percent
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value
Commitments mapped to the Government Social Value Model themes.
No social-value commitments yet
Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.